Investegate |NOVARTIS AG CHF0.50(REGD) Announcements | NOVARTIS AG CHF0.50(REGD): New long-term Leqvio® (inclisiran) data from Novartis show sustained efficacy and safety over four years
Investegate announcements from NOVARTIS AG CHF0.50(REGD), New long-term Leqvio® (inclisiran) data from Novartis show sustained efficacy and safety over four years